Literature DB >> 9152815

The Kobe earthquake and recurrent endogenous uveitis.

H Yamamoto1, A Azumi, J Sakai, M Yamamoto.   

Abstract

The mechanism of recurrent endogenous uveitis remains uncertain but it is generally believed to be affected by both heredity and environment. On January 17, 1995, the Hanshin-Awaji (Kobe) area of Japan experienced a major earthquake which killed more than 6300 people and forced 310,000 to take refuge in emergency shelters. All inhabitants of this area suffered severe stress due to the sudden changes in their living environment. We investigated the recurrence rate of endogenous uveitis before and after the earthquake in 116 patients who had been followed for more than 2 years (since July 17, 1993) at Kobe University Hospital. The postquake rate was significantly higher than the prequake rate (10% vs 3%); women were more often affected than men. Our data suggests that psychological stress due to the sudden changes in living conditions following the earthquake may have triggered the recurrences. It might be important to provide psychological as well as physical care for these patients after a disaster.

Entities:  

Mesh:

Year:  1997        PMID: 9152815     DOI: 10.1016/s0021-5155(97)00008-7

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  2 in total

1.  Retrospective analysis of Guillain-Barré syndrome and Fisher syndrome after the Great East Japan Earthquake.

Authors:  Hirofumi Tsuboi; Naoto Sugeno; Maki Tateyama; Ichiro Nakashima; Takafumi Hasegawa; Hiroshi Kuroda; Kimihiko Kaneko; Michiko Kobayashi; Aya Ishigaki; Juichi Fujimori; Masashi Aoki
Journal:  Brain Behav       Date:  2014-04-30       Impact factor: 2.708

2.  Perceived Stress Levels in Adult Patients With Uveitis.

Authors:  Rafael S Grajewski; Anna C Boelke; Werner Adler; Arina Pape; Falk Schroedl; Arno Hueber; Christian Albus; Frank Vitinius; Ludwig M Heindl
Journal:  Front Psychiatry       Date:  2020-01-08       Impact factor: 4.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.